Pershing Square Capital Management 13F holdings, Q2 2015
Holdings as of June 30, 2015 · filings on SEC EDGAR · latest filing →
Pershing Square Capital Management disclosed 7 US equity positions worth $14.4bn in its Q2 2015 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 29.9% of the reported book, followed by APD and CANADIAN PAC RY LTD. Against the Q1 2015 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 7 holdings.
What did Pershing Square Capital Management own in Q2 2015? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2015 |
|---|---|---|---|---|---|---|---|
| 1 | VALEANT PHARMACEUTICALS INTL | 29.9% | $4.3bn | 19,473,933 | 0% | held | |
| 2 | APD AIR PRODS & CHEMS INC | Basic Materials | 19.5% | $2.8bn | 20,549,076 | 0% | held |
| 3 | CANADIAN PAC RY LTD | 15.5% | $2.2bn | 13,940,890 | 0% | held | |
| 4 | ZTS ZOETIS INC | Healthcare | 14.0% | $2.0bn | 41,823,145 | 0% | held |
| 5 | QSR RESTAURANT BRANDS INTL INC | Consumer Cyclical | 10.1% | $1.5bn | 38,003,984 | 0% | held |
| 6 | PLATFORM SPECIALTY PRODS COR | 7.6% | $1.1bn | 42,737,394 | 0% | held | |
| 7 | HHH HOWARD HUGHES CORP | Real Estate | 3.5% | $512.2m | 3,568,017 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.